Health Canada Grants Authorization for “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Oc […]
TOKYO and CAMBRIDGE, Mass., Oc […]
香港, 2025年 […]
(SeaPRwire) – […]
HONG KONG, Oct 27, 2025 – […]
(SeaPRwire) – […]